Logo image of CBAN

COLONY BANKCORP (CBAN) Stock Fundamental Analysis

NYSE:CBAN - New York Stock Exchange, Inc. - US19623P1012 - Common Stock - Currency: USD

16.9  -0.38 (-2.2%)

After market: 16.9 0 (0%)

Fundamental Rating

4

CBAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 405 industry peers in the Banks industry. CBAN may be in some trouble as it scores bad on both profitability and health. CBAN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CBAN had positive earnings in the past year.
CBAN had a positive operating cash flow in the past year.
Each year in the past 5 years CBAN has been profitable.
In multiple years CBAN reported negative operating cash flow during the last 5 years.
CBAN Yearly Net Income VS EBIT VS OCF VS FCFCBAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With a Return On Assets value of 0.72%, CBAN perfoms like the industry average, outperforming 41.85% of the companies in the same industry.
CBAN's Return On Equity of 7.98% is in line compared to the rest of the industry. CBAN outperforms 49.12% of its industry peers.
Industry RankSector Rank
ROA 0.72%
ROE 7.98%
ROIC N/A
ROA(3y)0.71%
ROA(5y)0.7%
ROE(3y)8.52%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
CBAN Yearly ROA, ROE, ROICCBAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 19.53%, CBAN is doing worse than 63.16% of the companies in the same industry.
CBAN's Profit Margin has improved in the last couple of years.
CBAN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.53%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.26%
PM growth 5Y4.61%
GM growth 3YN/A
GM growth 5YN/A
CBAN Yearly Profit, Operating, Gross MarginsCBAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

CBAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBAN has been reduced compared to 1 year ago.
CBAN has more shares outstanding than it did 5 years ago.
CBAN has a better debt/assets ratio than last year.
CBAN Yearly Shares OutstandingCBAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CBAN Yearly Total Debt VS Total AssetsCBAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of CBAN is 2.02, which is a good value as it means it would take CBAN, 2.02 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.02, CBAN is in the better half of the industry, outperforming 60.40% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that CBAN is not too dependend on debt financing.
CBAN has a Debt to Equity ratio (0.23) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.02
Altman-Z N/A
ROIC/WACCN/A
WACC12.59%
CBAN Yearly LT Debt VS Equity VS FCFCBAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBAN Yearly Current Assets VS Current LiabilitesCBAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

CBAN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.65%.
Measured over the past 5 years, CBAN shows a small growth in Earnings Per Share. The EPS has been growing by 3.95% on average per year.
CBAN shows a small growth in Revenue. In the last year, the Revenue has grown by 1.38%.
CBAN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.31% yearly.
EPS 1Y (TTM)4.65%
EPS 3Y-12.13%
EPS 5Y3.95%
EPS Q2Q%31.25%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y4.05%
Revenue growth 5Y13.31%
Sales Q2Q%9.23%

3.2 Future

Based on estimates for the next years, CBAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.39% on average per year.
The Revenue is expected to grow by 7.54% on average over the next years.
EPS Next Y24.67%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.82%
Revenue Next 2Y7.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CBAN Yearly Revenue VS EstimatesCBAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CBAN Yearly EPS VS EstimatesCBAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.52, CBAN is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CBAN is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CBAN to the average of the S&P500 Index (29.62), we can say CBAN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.04, the valuation of CBAN can be described as reasonable.
70.68% of the companies in the same industry are more expensive than CBAN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, CBAN is valued rather cheaply.
Industry RankSector Rank
PE 12.52
Fwd PE 10.04
CBAN Price Earnings VS Forward Price EarningsCBAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CBAN is valued a bit cheaper than 73.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.47
EV/EBITDA N/A
CBAN Per share dataCBAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CBAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBAN's earnings are expected to grow with 18.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)3.17
EPS Next 2Y18.39%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.66%, CBAN has a reasonable but not impressive dividend return.
CBAN's Dividend Yield is comparable with the industry average which is at 3.19.
CBAN's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.66%

5.2 History

The dividend of CBAN is nicely growing with an annual growth rate of 16.90%!
CBAN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CBAN decreased in the last 3 years.
Dividend Growth(5Y)16.9%
Div Incr Years2
Div Non Decr Years2
CBAN Yearly Dividends per shareCBAN Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

CBAN pays out 35.66% of its income as dividend. This is a sustainable payout ratio.
The dividend of CBAN is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP35.66%
EPS Next 2Y18.39%
EPS Next 3YN/A
CBAN Yearly Income VS Free CF VS DividendCBAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
CBAN Dividend Payout.CBAN Dividend Payout, showing the Payout Ratio.CBAN Dividend Payout.PayoutRetained Earnings

COLONY BANKCORP

NYSE:CBAN (2/21/2025, 8:05:25 PM)

After market: 16.9 0 (0%)

16.9

-0.38 (-2.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-22 2025-01-22/amc
Earnings (Next)04-22 2025-04-22/amc
Inst Owners57.9%
Inst Owner Change-95.05%
Ins Owners3.84%
Ins Owner Change0%
Market Cap296.09M
Analysts80
Price Target19.51 (15.44%)
Short Float %0.52%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 2.66%
Yearly Dividend0.44
Dividend Growth(5Y)16.9%
DP35.66%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-05 2025-02-05 (0.115)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.91%
Min EPS beat(2)-3.47%
Max EPS beat(2)-0.35%
EPS beat(4)0
Avg EPS beat(4)-2.73%
Min EPS beat(4)-5.12%
Max EPS beat(4)-0.35%
EPS beat(8)2
Avg EPS beat(8)-0.39%
EPS beat(12)2
Avg EPS beat(12)-6.31%
EPS beat(16)5
Avg EPS beat(16)1.92%
Revenue beat(2)0
Avg Revenue beat(2)-1.91%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.64%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)-0.04%
Revenue beat(8)1
Avg Revenue beat(8)-2.33%
Revenue beat(12)2
Avg Revenue beat(12)-3.28%
Revenue beat(16)6
Avg Revenue beat(16)-1.68%
PT rev (1m)0.66%
PT rev (3m)6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)7.14%
EPS NY rev (3m)11.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.61%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 12.52
Fwd PE 10.04
P/S 2.62
P/FCF 9.47
P/OCF 9.13
P/B 1.07
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)1.35
EY7.99%
EPS(NY)1.68
Fwd EY9.96%
FCF(TTM)1.78
FCFY10.56%
OCF(TTM)1.85
OCFY10.95%
SpS6.44
BVpS15.76
TBVpS12.78
PEG (NY)0.51
PEG (5Y)3.17
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 7.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.53%
GM N/A
FCFM 27.7%
ROA(3y)0.71%
ROA(5y)0.7%
ROE(3y)8.52%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.26%
PM growth 5Y4.61%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.02
Debt/EBITDA N/A
Cap/Depr 14.14%
Cap/Sales 1.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 141.88%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC12.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.65%
EPS 3Y-12.13%
EPS 5Y3.95%
EPS Q2Q%31.25%
EPS Next Y24.67%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.38%
Revenue growth 3Y4.05%
Revenue growth 5Y13.31%
Sales Q2Q%9.23%
Revenue Next Year8.82%
Revenue Next 2Y7.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.93%
OCF growth 3YN/A
OCF growth 5YN/A